Product Images Leflunomide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Leflunomide NDC 59651-349 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
figure1 - leflunomide fig1
figure2 - leflunomide fig2
The text appears to be a graph or chart showing the percentage of responders over time for two treatments, labeled as "pPL-TF-MTX" and "A-LEF". The title suggests that this data is part of a clinical trial labeled as "Trial 1". However, without a visual representation of the graph, it is not possible to provide a more detailed description.*
figure3 - leflunomide fig3
figure4 - leflunomide fig4
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (30 Tablets Bottle Label) - leflunomide fig5
Each film-coated tablet contains Leflunomide USP 10 mg. The dosage and administration information can be found in the package insert. It is recommended to keep the tablets out of reach of children and stored at a controlled room temperature between 20-25 degrees Celsius. The tablets should also be protected from moisture. Distributed by Aurobindo Pharma USA, the tablets are manufactured in India. No useful information could be derived from "Over prnting Zone Coding Area".*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg (30 Tablets Bottle Label) - leflunomide fig6
structure - leflunomide str1
structure2 - leflunomide str2
This is a pharmaceutical drug with the name of teriflunomide, which has a code of F3C and a product code of A77 1726. No further information is available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.